METAVIA INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
METAVIA INC. (MTVA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.60% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-20
- METAVIA INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.60%.
- METAVIA INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.80%.
- METAVIA INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -1.50%, a 850.00% decline from fiscal 2021.
- METAVIA INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.60% 10-K · filed 2025-03-20 | |
| 2023-12-31 | -0.80% 10-K · filed 2025-03-20 | |
| 2022-12-31 | -1.50% 10-K · filed 2024-03-28 | |
| 2021-12-31 | 0.20% 10-K · filed 2023-03-30 | |
| 2020-12-31 | -0.80% 10-K · filed 2022-03-31 | |
| 2019-12-31 | -0.50% 10-K · filed 2021-04-15 | |
| 2018-12-31 | -0.40% 10-K · filed 2020-03-30 | 0.60% 10-K · filed 2019-03-18 |
| 2017-12-31 | 0.50% 10-K · filed 2019-03-18 | |
| 2016-12-31 | 1.40% 10-K · filed 2019-03-18 | |
| 2015-12-31 | 0.30% 10-K · filed 2018-03-20 | -0.80% 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |